ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Future Frontiers in Small Molecule Inhibitors of Protein-Protein Interactions

Journal: International Journal of Bioorganic Chemistry & Molecular Biology (IJBCMB) (Vol.01, No. e)

Publication Date:

Authors : ; ; ;

Page : 1-2

Keywords : Protein-Protein Interactions; paclitaxel (Taxol); tubulin heterodimer;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Protein-protein interactions (PPIs) are ubiquitous in essential biological processes such as cell proliferation and differentiation, host-pathogen interactions, and signal transduction pathways [1]. Pioneering advances in the field of interactomics have uncovered new net-works of protein interactions within cells, with esti-mates for the size of the interactome ranging up to 650,000 PPIs [2]. However, targeting PPIs has histori-cally been considered to be a particularly challenging task due to their typically large size (>1,500 Å) and amorphous nature that lack well-defined crevices for recognition by small molecules. Not surprisingly, the pharmaceutical landscape over the last century has been dominated by programs for small molecule in-hibitors of enzymes (particularly kinases), G-protein-coupled receptors, protein transporters and ion chan-nels that account for the majority of known drugs

Last modified: 2017-05-31 13:21:59